HER2+ EA1181

Study #EA1181

(CompassHER2-pCR): Preoperative THP and Posoperative HP in Patients who Achieve a Pathologic Complete Response Part 1 Component of: The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer)